Patents by Inventor Michel Bureau

Michel Bureau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for transferring nucleic acid into striated muscles
    Patent number: 6939862
    Abstract: The invention provides a method of transferring in vivo a molecule into a striated muscle cell. More specifically, a method of the invention comprises contacting in vivo a striated muscle cell with a molecule, and electrically stimulating the muscle cell with one or more unipolar pulses of an electric field intensity ranging from 1 to 800 V/cm2. In one embodiment, the molecule is a nucleic acid encoding a protein of interest. For example, the invention provides methods of promoting angiogenesis and hemostasis.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: September 6, 2005
    Assignees: Aventis Pharma S.A., Centre National de la Recherche Scientifique, Institut Gustave Roussy
    Inventors: Michel Bureau, Lluis Mir, Daniel Scherman
  • Method for transferring nucleic acid into striated muscles
    Publication number: 20030073653
    Abstract: The invention provides a method of transferring in vivo a molecule into a striated muscle cell. More specifically, a method of the invention comprises contacting in vivo a striated muscle cell with a molecule, and electrically stimulating the muscle cell with one or more unipolar pulses of an electric field intensity ranging from 1 to 800 V/cm2. In one embodiment, the molecule is a nucleic acid encoding a protein of interest. For example, the invention provides methods of promoting angiogenesis and hemostasis.
    Type: Application
    Filed: November 7, 2001
    Publication date: April 17, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Michel Bureau, Lluis Mir, Daniel Scherman
  • Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
    Patent number: 6528315
    Abstract: The invention concerns an improved method for transferring in vivo multicelled eukaryotic organism cells nucleic acids or nucleic acids combined with products for enhancing the efficacy of such transfers. The invention also concerns the combination of a nucleic acid and the transfer method for use in gene therapy.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: March 4, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Michel Bureau, Lluis Mir, Daniel Scherman
  • METHOD FOR TRANSFERRING NUCLEIC ACID INTO MULTICELLED EUKARYOTIC ORGANISM CELLS AND COMBINATION THEREFOR
    Publication number: 20020012914
    Abstract: The invention concerns an improved method for transferring in vivo multicelled eukaryotic organism cells nucleic acids or nucleic acids combined with products for enhancing the efficacy of such transfers. The invention also concerns the combination of a nucleic acid and the transfer method for use in gene therapy.
    Type: Application
    Filed: February 2, 2000
    Publication date: January 31, 2002
    Inventors: MICHEL BUREAU, LLUIS MIR, DANIEL SCHERMAN